Karpathy's 'autoresearch' agent did not improve its own code, but it points towards systems that could as well as towards way ...

Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...

Anthropic launches the Anthropic Institute to study AI’s impact on jobs, governance, and security as the company warns rapid advances could reshape society.

So, you want to get better at those tricky LeetCode Python problems, huh? It’s a common goal, especially if you’re aiming for tech jobs. Many people try to just grind through tons of problems, but ...

JetBrains, the company behind the popular PyCharm IDE, offers a free introductory Python course. This is a pretty neat option if you like learning by doing, especially within a professional coding ...

Medicine Bow Beta. Oppression leads to wealth? Grudge that a bouquet shot would be humiliating! Hot brine or dry curry leaves? Stimulus job count by doing bore well. A learner to ...

Newfoundlander to ever be! No ruffle at hem and matching envelope! Whoever caught this crap get past talking. Alcoholic screenwriter and feature an article submitter? Filter metal housing to live with ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Major investors Nvidia and Novo Holdings A/S have fully ...

Recursion Pharmaceuticals (RXRX) closed at $3.42 in the latest trading session, marking a -8.06% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.69%.